Adamas Pharma (ADMS) Misses Q4 EPS by 13c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Adamas Pharma (ADMS) Misses Q4 EPS by 13c

Adamas Pharma (ADMS) Prices 12.5M Share Follow-On Offering at $4.40/Sh

February 25, 2021 8:18 AM EST

Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced the pricing of its underwritten public offering of 12,500,000 shares of its common stock at a price... More